Tesla has normally been a good investment. While it hasn't always outperformed the market, the automotive stock has generated ...

Before diving in, let's trace Nvidia's path to $4 trillion. Nvidia has seen its market capitalization surge in a short period ...

Key Points The airline industry has undergone significant changes, and Delta Air Lines is at the forefront of achieving ...

Unilever's stock and cash flow rise via price hikes, yet real growth lags. Read here for UL stock's Growth Action Plan's ...

Fuchs SE is backed by R&D, market share growth, and megatrends like e-mobility, it thrives amidst risks. See here to know why ...

Wall Street closed its third winning week in the last four with a quiet finish on Friday. The S&P 500 edged down by a whisper ...

One of biotech’s highest fliers, Sarepta Therapeutics, lost more than a third of its market value on Friday after executives said that one of its experimental gene-replacement therapies was linked to ...

WY Biotech is now obligated to pay a $7 million upfront license fee to HCW Biologics by Sept. 30, according to a filing with the Securities and Exchange Commission. HCW Biologics previously said it ...

Stocks turned in a lackluster performance Friday as Wall Street took a breather at the end of the first week of ...

Comerica (NYSE:CMA) reported its Q2 2025 earnings on July 18, reporting EPS of $1.42 (up nearly 14% sequentially). In the quarter, it returned $193 million to shareholders through stock repurchases ...